Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
85.82%
-
Total 13F principal
-
$309,106,035
-
Principal change
-
-$15,405,715
-
Total reported market value
-
$265,334,000
-
Number of holders
-
40
-
Value change
-
-$13,035,586
-
Number of buys
-
22
-
Number of sells
-
15
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q2 2017
As of 30 Jun 2017,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$309,106,035
in principal (par value) of the bond.
The largest 10 bondholders included
BAKER BROS. ADVISORS LP, WOLVERINE ASSET MANAGEMENT LLC, CANYON CAPITAL ADVISORS LLC, CNH PARTNERS LLC, Davidson Kempner Capital Management LP, CITADEL ADVISORS LLC, D. E. Shaw & Co., Inc., AMERIPRISE FINANCIAL INC, Partner Fund Management, L.P., and UBS Group AG.
This page lists
40
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.